Fluxmed GrH portable pneumotachograph
DeviceFluxmed GrH portable pneumotachograph is used to measure the given ventilation. It is placed on the chosen airway adjunct and passively measures ventilation parameters such as volumes, and flow.
NCT Number: NCT04237727
The aim of this observational study is to investigate how ventilations is given during cardiopulmonary resuscitation (CPR) given by advanced life support providers (ALS). A portable device capable of detailed measurments of ventilation will be used when ventilating patients suffering cardiac arrest.
The main objective of the study is to describe the ventilatiosn given in terms of volume, frequency and pressure, both overall and during different CPR modes and when using different methods to handle the patients airway.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Regionale Ambulance Voorziening Utrecht, Netherlands, Amersfoort, Utrecht, Netherlands
The aim with this observational multicenter study is to measure and describe manual ventilation during cardiopulmonary resuscitation in the advance life support setting.
Primary endpoint is the ventilation quality measured as ventilation frequency, tidal volume, minute ventilation peak inspiratory pressure and exhaled CO2.
This will be studied in both asycnhronous ventilations, meaning ventilations that are given during ongoing chest compressions and syncrhonous ventilations, meaning ventilations given during a pause of the chest compressions, in a 30:2 repeatign pattern. Aditionally, airway modalities such as bag-valve-masks, Supraglottic airway devices and endotracheal tubes will be studied.
The inclusion of patients will be performed at five sites, The Uppsala emergency medical services, Uppsala, Sweden, Capio AB akutläkarbilar (rapid response cars), Stockholm Sweden, Falun County hospital, Falun, Sweden, EMS Amsterdam post West, Amsterdam, The Netherlands and Lifeliner 1 HEMS, Amsterdam, The Netherlands Eligible for inclusion are patients over 18 years old suffering cardiac arrest in the areas served by the including emergency medical systems and in-hospital emergency team.
The goal is to include at least 200 patients.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Out-of-hospital cardiac arrest (OHCA) treated with CPR performed by the EMS personnel
Exclusion criteria
Fluxmed GrH portable pneumotachograph is used to measure the given ventilation. It is placed on the chosen airway adjunct and passively measures ventilation parameters such as volumes, and flow.
Time frame: 1 Day
Measured as ventilations per minute.
Time frame: 1 Day
Measured as milliliters per ventilation.
Time frame: 1 Day
Measured as litres per minute.
Time frame: 1 Day
etCO2 measured as kilopascal for each exhalation during CPR with 30 compressions and 2 ventilations and during continous compressions and ventilations.
Time frame: 1 Day
Measured as seconds for each inspiration.
Time frame: 1 Day
Dead space measured as milliliters for each ventilation compared to the tidal volume in milliters for that same ventilation.
Time frame: 1 Day
Measured as cmH20 for each ventilation.
Time frame: 1 Day
If the patient, as stated by the ALS provider, has spontaneous circultation during the resuscitation attempt
Uppsala University
Other
Acronym: CAvent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04988906
Cardiovascular Diseases, Heart Arrest
Toronto, Ontario, Canada
View Trial DetailsNCT05550454
Advanced Cardiac Life Support, Cardiovascular Diseases
Seoul, Korea (the Republic Of), South Korea
View Trial DetailsNCT03835403
Cardiovascular Diseases, Heart Arrest
Copenhagen, Ballerup, Denmark
View Trial DetailsNCT02309151
Cardiovascular Diseases, Heart Arrest
Aalborg, Denmark
View Trial Details